Skip to content
Screener

LivaNova LIVN Investing Cash Flow

Investing Cash Flow at other companies

Abbott logo
AbbottABT
-$673M-15.6%
Haemonetics logo
HaemoneticsHAE
-$22.23M+32.6%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$117K-216%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$11.25M-624%
Medtronic logo
MedtronicMDT
-$917M-87.1%
ITG
Integer HoldingsITGR
-$37.9M+80.8%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases of property, plant, and equipment(45,840)(25,937)
Proceeds from investments6,522
Other, net(657)(181)
Net cash used in investing activities(46,497)(19,596)
Financing Activities:
Repayment of long-term debt obligations(95,938)(210,250)
Payment of contingent consideration(50,429)
Other, net(4,326)(3,153)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's investing cash flow?
LivaNova (LIVN) reported investing cash flow of -$31.92M in Q2 2026.
How has LivaNova's investing cash flow changed year-over-year?
LivaNova's investing cash flow decreased by 255.9% year-over-year, from -$8.97M to -$31.92M.
What is the long-term trend for LivaNova's investing cash flow?
Over 3 years (2022 to 2025), LivaNova's investing cash flow has grown at a 23.8% compound annual growth rate (CAGR), from -$38.41M to -$72.91M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about LivaNova's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude